comparemela.com

Latest Breaking News On - University hospitals gasthuisberg - Page 1 : comparemela.com

Nearly half of patients with giant cell arteritis achieve remission with upadacitinib

Nearly half of patients with giant cell arteritis achieve remission with upadacitinib
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Region flamandeShenaz baghaDaniel blockmansKori wallaceUniversity hospitals gasthuisberg

Upadacitinib Looks Promising for Patients With Giant Cell Arteritis

The phase 3 SELECT-GCA study evaluated the efficacy and safety of upadacitinib in patients 50 years of age and older with GCA.

Region flamandeDaniel blockmansUniversity hospitals gasthuisbergGeneral internal medicine

AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis

AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Region flamandeDaniel blockmansKori wallaceUniversity hospitals gasthuisbergGeneral internal medicine

Phase 3 Upadacitinib Study Achieves Positive Results for the Treatment of Giant Cell Arteritis

Results of the SELECT-GCA study demonstrated approximately half of patients with giant cell arteritis treated with upadacitinib plus a steroid tapering regimen were able to achieve sustained remission through week 52.

Region flamandeDaniel blockmansKori wallaceMedicine at university hospitals gasthuisbergGeneral internal medicineUniversity hospitals gasthuisberg

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for

Region flamandeDavid libergVan cutsemDominique tersagoEric van cutsemPrnewswire cantargiaUniversity hospitals gasthuisbergVp researchUniversity of warsawBelgian foundationNasdaq stockholmDivision headDigestive oncologyEric vanMedical universityProf van cutsem

vimarsana © 2020. All Rights Reserved.